Shareholders' Equity

12 Months Ended

Dec. 31, 2019

20. Shareholders’ Equity (Deficiency)

Changes in our ordinary shares issued were as follows:



(Shares in millions)	Issued
Balance at December 31, 2017 (Predecessor)	993
Equity Awards Granted, Vested and Exercised	9
Balance at December 31, 2018 (Predecessor)	1,002
Equity Awards Granted, Vested and Exercised	7
Predecessor Shares Cancellation	(1,009	)
Balance at December 13, 2019 (Predecessor)	—
Share Issuance	70
Balance at December 13, 2019 (Successor)	70
Share Issuance	—
Balance at December 31, 2019 (Successor)	70

Upon the effectiveness of the Plan, all previously issued and outstanding equity interests in the Predecessor were cancelled and the Company issued 69,999,954 “New Ordinary Shares” to the holders of the Company’s existing senior notes and holders of “Old Ordinary Shares”. The amount in excess of par value of $2.9 billion is reported in Capital in Excess of Par Value on the accompanying Consolidated Balance Sheets.

On the Effective Date, the Company issued New Warrants to holders of the Company’s Old Ordinary Shares, to purchase up to an aggregate of 7,777,779 New Ordinary Shares in the Company, par value $0.001, at an exercise price of $99.96 per ordinary share. The New Warrants are equity classified and, upon issuance, have a value of $31 million, which was recorded in “Capital in Excess of Par Value.” At December 31, 2019 no warrants had been exercised. The warrant fair value was a Level 2 valuation and is estimated using the Black Scholes valuation model. Inputs to the model include Weatherford’s share price, volatility of our share price, and the risk-free interest rate.

The New Warrants are exercisable until “Expiration Date” of which is the earlier of (i) December 13, 2023 and (ii) the date of consummation of any liquidity event resulting in the sale or exchange of all or substantially all of the equity interests of the Company to one or more third parties (whether by merger, sale, recapitalization, consolidation, combination or otherwise) or the sale, directly or indirectly, by the Company of all or substantially all of the assets of the Company and its Subsidiaries, taken as a whole; or a liquidation, dissolution or winding up of the Company. All unexercised New Warrants will expire, and the rights of the warrant holders to purchase New Ordinary Shares will terminate, on the Expiration Date.

On November 21, 2016, we issued 84.5 million ordinary shares at a price of $5.40 per ordinary share, and a warrant (“Old Warrant”) to purchase 84.5 million ordinary shares on or prior to May 21, 2019 at an exercise price of $6.43 per ordinary share to a selected institutional investor. On May 21, 2019, the Old Warrant option period lapsed and the warrants expired unexercised.

Accumulated Other Comprehensive Loss

The following table presents the changes in our accumulated other comprehensive loss by component:



(Dollars in millions)	Currency Translation Adjustment			Defined Benefit Pension			Deferred Loss on Derivatives			Total
Balance at December 31, 2017 (Predecessor)	$	(1,484	)	$	(26	)	$	(9	)	$	(1,519	)
Other Comprehensive (Loss) Income before Reclassifications	(240		)	10			—			(230		)
Reclassifications	—			2			1			3
Net Activity	(240		)	12			1			(227		)
Balance at December 31, 2018 (Predecessor)	(1,724		)	(14		)	(8		)	(1,746		)
Other Comprehensive Income (Loss) before Reclassifications	52			(12		)	—			40
Reclassifications	—			1			8			9
Net Activity	52			(11		)	8			49
Balance at December 13, 2019 (Predecessor)	(1,672		)	(25		)	—			(1,697		)
Elimination of Predecessor Equity Balances	1,672			25			—			1,697
Balance at December 13, 2019 (Successor)	—			—			—			—
Other Comprehensive Income	7			2			—			9
Balance at December 31, 2019 (Successor)	$	7		$	2		$	—		$	9